Phenomix Sciences

Phenomix Sciences an early-stage spinout of the Mayo Clinic focused on personalized treatments for chronic diseases.

Launch date

2021

Employees

Market cap

Enterprise valuation

Saint Paul Minnesota (HQ)

Date	Investors	Amount	Round
Nov 2018	N/A	$1.0m	Seed
Oct 2019	Securian Financial Group	$10.0k	Grant
Feb 2023*	N/A	$1.0m	Early VC
May 2024*	LabCorp Dexcom Health2047	$5.5m	Series A
May 2024*	National Institutes of Health	$2.3m	Grant
Total Funding		$9.8m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Phenomix Sciences